River BioMedics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.2M

  • Investors
  • 6

River BioMedics General Information

Description

Developer of three-D cardiac models intended to offer new human cardiac models for target validation during drug discovery. The company provides highly informative, clinically relevant readouts, granting an in-depth understanding of the effects of compounds on overall cardiac function and screening tools, enabling healthcare professionals to target validation for the discovery and development of novel cardiac drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Office ZH124
  • Drienerlolaan 5
  • 7522 NB Enschede
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Office ZH124
  • Drienerlolaan 5
  • 7522 NB Enschede
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

River BioMedics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 07-May-2023 $2.2M Completed Product Development
4. Seed Round 20-Jan-2022 Completed Product Development
3. Grant 20-Feb-2020 Completed Product Development
2. Accelerator/Incubator 08-Oct-2018 Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view River BioMedics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

River BioMedics Patents

River BioMedics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12584085-B2 Microfluidic device for a 3d tissue structure Active 09-Apr-2020
US-20230137145-A1 Microfluidic device for a 3d tissue structure Active 09-Apr-2020
WO-2021206551-A1 Microfluidic device for a 3d tissue structure Inactive 09-Apr-2020 C12M21/08

River BioMedics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

River BioMedics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Libertatis Ergo Holding (LEH) Venture Capital Minority
BioGeneration Ventures Venture Capital Minority
KIKK Capital Venture Capital Minority
Oost NL Venture Capital Minority
Netherlands Organisation for Scientific Research (Netherlands) Government
You’re viewing 5 of 6 investors. Get the full list »

River BioMedics FAQs

  • When was River BioMedics founded?

    River BioMedics was founded in 2018.

  • Where is River BioMedics headquartered?

    River BioMedics is headquartered in Enschede, Netherlands.

  • What is the size of River BioMedics?

    River BioMedics has 11 total employees.

  • What industry is River BioMedics in?

    River BioMedics’s primary industry is Drug Discovery.

  • Is River BioMedics a private or public company?

    River BioMedics is a Private company.

  • What is River BioMedics’s current revenue?

    The current revenue for River BioMedics is .

  • How much funding has River BioMedics raised over time?

    River BioMedics has raised $4.25M.

  • Who are River BioMedics’s investors?

    Libertatis Ergo Holding (LEH), BioGeneration Ventures, KIKK Capital, Oost NL, and Netherlands Organisation for Scientific Research (Netherlands) are 5 of 6 investors who have invested in River BioMedics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process